Éditeur U.S. Government Accountability Office (GAO)

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Opioid use disorder. Treatment with injectable and implantable buprenorphine. Report to Congressional Committees

United States Government Accountability Office | 2020
Rapport

Treatment for opioid use disorder may involve buprenorphine - a drug that can reduce or eliminate withdrawal symptoms and prevent relapse. We reviewed the use of long-acting injectable and implantable forms of buprenorphine for opioid use disor[...]

Plus d'info

Ajouter à la sélection

Lien externe